Press Release Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference 8 hours ago
Press Release Elicio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Updates Aug 13
Press Release Elicio Therapeutics Announces Activation of the Investigator-Initiated Phase 1 Study of Neoadjuvant ELI-002 7P for Pancreatic Ductal Adenocarcinoma Aug 10